Register entry
AYRMID PHARMA LTD
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 2
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
2| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 12257285 | APHEXDAmotixafortide acetate | product | Dec 2041 |
| 12268725 | APHEXDAmotixafortide acetate | product | Dec 2041 |
| Product | Exclusivity | Until |
|---|---|---|
| APHEXDAMOTIXAFORTIDE ACETATE | ODE-442 Orphan drug | Sept 2030 |
Enquiry
Common questions
- Is AYRMID PHARMA LTD FDA approved?
- AYRMID PHARMA LTD holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.